Suzhou
688266.SSSuzhou Zelgen Biopharmaceuticals Co., Ltd. Price (688266.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
255,580,499
(6.4919)%Cash Flow Statement
Suzhou Zelgen Biopharmaceuticals Co., Ltd.Currency: CNY
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -128,267,868.56
+0% |
-146,468,448.06
+14% |
-441,877,485.20
+202% |
-447,983,564.07
+1% |
-310,675,338.01
-31% |
-461,990,822.51
+49% |
-485,949,358.10
+5% |
-295,134,953.99
-39% |
|||||||||||
| Depreciation And Amortiz... | 5.73M | 4.97M | 13.84M | 33.00M | 34.72M | 50.77M | 66.37M | 54.83M | |||||||||||
| Deferred Income Tax | 0.00 | 0.00 | -780,400.00 | -4,346,994.00 | -4,080,258.00 | -3,631,296.00 | -2,443,053.00 | 0.00 | |||||||||||
| Stock-Based Compensat... | 68.02M | 0.00 | 309.05M | 237.45M | 31.12M | 34.62M | 37.07M | 0.00 | |||||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | -9,309,800.00 | -4,114,000.00 | -3,862,700.00 | -11,006,548.00 | -20,870,366.00 | -84,190,822.00 | -17,411,835.00 | -38,353,828.00 | |||||||||||
| Accounts Payables | 8.23M | 39.45M | 21.55M | 16.16M | -46,680,421.00 | 38.99M | 67.14M | 78.49M | |||||||||||
| Inventory | -74,169.67 | -314,297.33 | -2,073,523.91 | -3,871,737.82 | -16,712,597.28 | -28,773,222.70 | -47,067,327.18 | -11,874,030.00 | |||||||||||
| Other Working Capital | -1,082,343.89 | 35.33M | 16.90M | -4,346,995.00 | -4,080,260.12 | -3,631,296.05 | -2,443,054.82 | -3,739,445.00 | |||||||||||
| Other Non-Cash Items | 66.97M | -1,768,286.56 | 300.77M | 4.52M | -6,596,640.84 | 3.21M | 14.40M | -4,534,259.01 | |||||||||||
| Net Cash Provided By Op... | -56,720,193.29
+0% |
-108,251,624.80
+91% |
-112,437,479.94
+4% |
-180,427,947.30
+60% |
-343,856,869.25
+91% |
-454,623,223.39
+32% |
-370,342,567.26
-19% |
-220,313,121.00
-41% |
|||||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | -24,319,746.27 | -11,657,156.64 | -11,081,362.85 | -15,105,307.37 | -57,680,675.11 | -70,738,589.25 | -88,623,523.55 | -62,601,229.00 | |||||||||||
| Acquisitions Net | 24.32M | 0.00 | -15,457,926.15 | 15.11M | 57.68M | -8,356,738.00 | -24,221,546.00 | 0.00 | |||||||||||
| Purchases Of Investments | -226,000,000.00 | -121,000,000.00 | -344,900,000.00 | -195,000,000.00 | -1,135,010,000.00 | -520,000,000.00 | -943,097,400.00 | -1,135,000,000.00 | |||||||||||
| Sales Maturities Of Inve... | 192.89M | 122.95M | 317.60M | 273.43M | 693.44M | 917.40M | 767.66M | 1.25B | |||||||||||
| Other Investing Activities | -24,319,746.27 | 879.59k | 728.54k | -15,105,307.63 | -57,680,674.37 | 8.36M | 24.23M | 2.60k | |||||||||||
| Net Cash Used For Inv... | -57,426,025.69
+0% |
-8,826,929.53
-85% |
-53,112,595.17
+502% |
63.33M
-219% |
-499,253,243.48
-888% |
326.66M
-165% |
-264,055,999.16
-181% |
52.40M
-120% |
|||||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | 0.00 | 0.00 | 0.00 | 60.00M | -12,350,000.00 | 106.49M | 318.23M | 353.80M | |||||||||||
| Common Stock Issued | 0.00 | 0.00 | 0.00 | -4,542,452.00 | -113,100,440.00 | 0.00 | 0.00 | -1,446,338.00 | |||||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 4.54M | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Dividends Paid | 0.00 | 0.00 | 0.00 | -1,159,999.97 | -1,110,688.39 | -4,141,156.73 | -11,216,267.61 | -21,174,721.00 | |||||||||||
| Other Financing Activities | 124.79M | 110.06M | 285.37M | 20.67k | 1.91B | -8,356,842.00 | -24,225,547.00 | 1.18B | |||||||||||
| Net Cash Used/Provide... | 124.79M
+0% |
110.06M
-12% |
285.37M
+159% |
54.32M
-81% |
1.90B
+3,396% |
93.99M
-95% |
282.79M
+201% |
1.51B
+434% |
|||||||||||
| Effect Of Forex Changes... | 54.22k | -117,844.55 | -776,769.18 | 768.53k | -3,794,045.60 | -1,437,534.14 | 4.07M | 216.72k | |||||||||||
| Net Change In Cash | 10.70M | -7,140,888.00 | 119.05M | -62,012,086.00 | 1.05B | -35,409,876.00 | -347,538,638.00 | 1.34B | |||||||||||
| Cash At Beginning Of Per... | 6.33M | 17.03M | 9.88M | 128.93M | 66.92M | 1.12B | 1.08B | 736.11M | |||||||||||
| Cash At End Of Period | 17.03M | 9.88M | 128.93M | 66.92M | 1.12B | 1.08B | 736.11M | 2.08B | |||||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | -56,720,193.29 | -108,251,624.80 | -112,437,479.94 | -180,427,947.30 | -343,856,869.25 | -454,623,223.39 | -370,342,567.26 | -232,750,651.00 | |||||||||||
| Capital Expenditure | -24,319,746.27 | -11,657,156.64 | -11,081,362.85 | -15,105,307.37 | -57,680,675.11 | -70,738,589.25 | -88,623,523.55 | -62,601,229.98 | |||||||||||
| Free Cash Flow | -81,039,939.56
+0% |
-119,908,781.44
+48% |
-123,518,842.79
+3% |
-195,533,254.67
+58% |
-401,537,544.36
+105% |
-525,361,812.64
+31% |
-458,966,090.81
-13% |
-295,351,879.55
-36% |
|||||||||||